ResourceClinical Diagnostics
Testing Robustness: Immunosuppressant Drugs in Blood with a TSQ Quantis MS for Clinical Research
2 Mar 2018Mass spectrometry is a popular choice of technology in clinical research for the quantitation of immunosuppressant drugs in whole blood samples. A sensitive and robust instrument is required for reliable quantitation workflows. In this study, the robustness of the TSQ Quantis triple quadrupole mass spectrometer for analysis of immunosuppressant drugs in whole blood samples in demonstrated.
Links
Tags
HematologyIn Haematology / Hematology, complete blood cell counts (or full blood counts) are obtained using automated blood count analyzers to enumerate blood cell types. Hematology also encompasses haemostasis and coagulation, thrombophilia and hemophilia, plasma viscosity and ESR analysis, hemoglobinopathies, cell morphology and haematinic measurement.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical Mass SpectrometryMass spectrometry is emerging as a superior method of analysis over the longstanding, gold standard of immunoassay. Clinical mass spectrometry systems are increasingly accessible to medical laboratories and are capable of providing results with more speed and less expense than traditional methods. From simple mass spectrometers to IVDR class A compliant, highly sophisticated systems performing liquid chromatography tandem mass spectrometry (LC/MS/MS), find the latest product news, reviews and resources to make a purchasing decision for your laboratory.

